Castration-Resistant Prostate Carcinoma

Castration-Resistant Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

553 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 222
Recruiting: 123
Ph III recruiting: 12
Growth YoY: +25%
Industry share: 45%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (94)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07641855	A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer	not yet recruiting	Phase 2 / Phase 3	180	Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY	1	Jul 23, 2026	clinicaltrials
NCT06768255	Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC(mCRPC)	not yet recruiting	Phase 3	400	Ding-Wei YeOTHER	1	Jan 10, 2025